Author Index

Search or browse for an author across our entire electronic archive

Search results for: K
Results 81 - 90 of 1824 shown below

  • Kairemo, K J A

    T Erselcan, K J A Kairemo, T A Wiklund, M Hernberg, C P Blomqvist, M Tenhunen, J Bergh and H Joensuu

    Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer

    doi:10.1054/bjoc.1999.0998

  • Kaisary, A V

    M H Winkler, F A Khan, M Shabir, A Okeke, M Sugiono, P McInerney, G B Boustead, R Persad, A V Kaisary and D A Gillatt

    Contemporary update of cancer control after radical prostatectomy in the UK

    advance online publication, 2004-11-02 00:00:00.000;

    doi:10.1038/sj.bjc.6602206

  • J A Hamilton, L M D Stewart, L Ajayi, I C Gray, N E Gray, K G Roberts, G J Watson, A V Kaisary and D Snary

    The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers

    doi:10.1054/bjoc.2000.1211

  • Kaiser, G

    S D Fosså, B Paluchowska, A Horwich, G Kaiser, P H M de Mulder, O Koriakine, A T van Oosterom, L de Prijck, L Collette and R de Wit

    Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)

    advance online publication, 2005-10-25 00:00:00.000;

    doi:10.1038/sj.bjc.6602830

  • Kaiser, S A

    A S Levenson, I L Kliakhandler, K M Svoboda, K M Pease, S A Kaiser, J E Ward, III and V C Jordan

    Molecular classification of selective oestrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing oestrogen receptor alpha

    doi:10.1038/sj.bjc.6600477

  • Kaiser, U

    G Huebner, H Link, C H Kohne, M Stahl, A Kretzschmar, S Steinbach, G Folprecht, H Bernhard, S E Al-Batran, P Schoffski, C Burkart, F Kullmann, B Otremba, M Menges, M Hoffmann, U Kaiser, A Aldaoud and A Jahn

    Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial

    advance online publication, 2008-12-09 00:00:00.000;

    doi:10.1038/sj.bjc.6604818

  • Kaito, M

    H Tanaka, N Fujita, R Sugimoto, N Urawa, S Horiike, Y Kobayashi, M Iwasa, N Ma, S Kawanishi, S Watanabe, M Kaito and Y Takei

    Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C

    advance online publication, 2008-01-29 00:00:00.000;

    doi:10.1038/sj.bjc.6604204

  • Kaizaki, R

    M Yashiro, O Shinto, K Nakamura, M Tendo, T Matsuoka, T Matsuzaki, R Kaizaki, M Ohira, A Miwa and K Hirakawa

    Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model

    doi:10.1038/sj.bjc.6605296

  • Kajanti, M

    A Anttonen, M Kajanti, P Heikkilä, M Jalkanen and H Joensuu

    Syndecan-1 expression has prognostic significance in head and neck carcinoma

    doi:10.1038/sj.bjc.6690088

  • Kajikawa, S

    M Mihara, Y Nimura, S Ichimiya, S Sakiyama, S Kajikawa, W Adachi, J Amano and A Nakagawara

    Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma

    doi:10.1038/sj.bjc.6690027

  • Kajita, T

    T Kajita, Y Ohta, K Kimura, M Tamura, Y Tanaka, Y Tsunezuka, M Oda, T Sasaki and Go Watanabe

    The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer

    doi:10.1054/bjoc.2001.1882